Abstract

BackgroundChronic obstructive pulmonary disease (COPD) is a major cause of mortality. Patients with advanced disease often have a poor quality of life, such that guidelines recommend providing palliative care in their last year of life. Uptake and use of palliative care in advanced COPD is low; difficulty in predicting 1-year mortality is thought to be a major contributing factor.MethodsWe identified two primary care COPD cohorts using UK electronic healthcare records (Clinical Practice Research Datalink). The first cohort was randomised equally into training and test sets. An external dataset was drawn from a second cohort. A risk model to predict mortality within 12 months was derived from the training set using backwards elimination Cox regression. The model was given the acronym BARC based on putative prognostic factors including body mass index and blood results (B), age (A), respiratory variables (airflow obstruction, exacerbations, smoking) (R) and comorbidities (C). The BARC index predictive performance was validated in the test set and external dataset by assessing calibration and discrimination. The observed and expected probabilities of death were assessed for increasing quartiles of mortality risk (very low risk, low risk, moderate risk, high risk). The BARC index was compared to the established index scores body mass index, obstructive, dyspnoea and exacerbations (BODEx), dyspnoea, obstruction, smoking and exacerbations (DOSE) and age, dyspnoea and obstruction (ADO).ResultsFifty-four thousand nine hundred ninety patients were eligible from the first cohort and 4931 from the second cohort. Eighteen variables were included in the BARC, including age, airflow obstruction, body mass index, smoking, exacerbations and comorbidities. The risk model had acceptable predictive performance (test set: C-index = 0.79, 95% CI 0.78ā€“0.81, D-statistic = 1.87, 95% CI 1.77ā€“1.96, calibration slope = 0.95, 95% CI 0.9ā€“0.99; external dataset: C-index = 0.67, 95% CI 0.65ā€“0.7, D-statistic = 0.98, 95% CI 0.8ā€“1.2, calibration slope = 0.54, 95% CI 0.45ā€“0.64) and acceptable accuracy predicting the probability of death (probability of death in 1 year, n high-risk group, test set: expected = 0.31, observed = 0.30; external dataset: expected = 0.22, observed = 0.27). The BARC compared favourably to existing index scores that can also be applied without specialist respiratory variables (area under the curve: BARC = 0.78, 95% CI 0.76ā€“0.79; BODEx = 0.48, 95% CI 0.45ā€“0.51; DOSE = 0.60, 95% CI 0.57ā€“0.61; ADO = 0.68, 95% CI 0.66ā€“0.69, external dataset: BARC = 0.70, 95% CI 0.67ā€“0.72; BODEx = 0.41, 95% CI 0.38ā€“0.45; DOSE = 0.52, 95% CI 0.49ā€“0.55; ADO = 0.57, 95% CI 0.54ā€“0.60).ConclusionThe BARC index performed better than existing tools in predicting 1-year mortality. Critically, the risk score only requires routinely collected non-specialist information which, therefore, could help identify patients seen in primary care that may benefit from palliative care.

Highlights

  • Chronic obstructive pulmonary disease (COPD) is associated with significant mortality and morbidity and is one of the most prevalent chronic diseases globally; in the United Kingdom (UK), it is the fifth highest cause of death [1, 2]

  • Characteristics of the COPD populations There were 54,990 eligible COPD patients in the first cohort, from which the training and test datasets were drawn, of whom 21% died during study follow-up; median follow-up was 2.7 years (Additional file 1)

  • The cohort had a median age of 70 years, around half were male, median BMI corresponding to overweight and a median FEV1 of 1.48 L (Table 1)

Read more

Summary

Introduction

Chronic obstructive pulmonary disease (COPD) is associated with significant mortality and morbidity and is one of the most prevalent chronic diseases globally; in the UK, it is the fifth highest cause of death [1, 2]. One major barrier to provision is the challenge of predicting patient survival, due to the irregular disease trajectory of COPD, which is usually one of slow decline, punctuated by sudden unpredictable exacerbations that often end in death [4, 8,9,10]. This is in contrast to lung cancer, where there is often a reasonable level of physical function until a short period of relatively predictable decline. Uptake and use of palliative care in advanced COPD is low; difficulty in predicting 1-year mortality is thought to be a major contributing factor

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.